Financhill
Sell
48

ADCT Quote, Financials, Valuation and Earnings

Last price:
$3.25
Seasonality move :
-27.31%
Day range:
$3.13 - $3.38
52-week range:
$1.05 - $4.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.43x
P/B ratio:
--
Volume:
635.7K
Avg. volume:
904.5K
1-year change:
-18.95%
Market cap:
$322.3M
Revenue:
$70.8M
EPS (TTM):
-$1.45

Earnings Data

Next earnings date for ADCT
Aug 06
2025
Most recent earnings per share
-$0.36
Missed by $0.36
(May 14/2025)
Consensus Estimate
--
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $18.3M -- -- -- --
08/06/2025 Q2 $17.9M -- -- -- --
05/14/2025 Q1 $17.7M $23M -$0.36 -- --
03/27/2025 Q4 $19M $16.9M -$0.29 -- --
11/07/2024 Q3 $18.5M $18.5M -$0.42 -- --
08/06/2024 Q2 $18.8M $17.4M -$0.38 -- --
05/06/2024 Q1 $18.1M $18.1M -$0.56 -- --
03/13/2024 Q4 $15.3M $16.8M -$1.04 -- --
11/07/2023 Q3 $15.2M $14.5M -$0.57 -- --
08/08/2023 Q2 $20.1M $19.3M -$0.60 -- --
05/09/2023 Q1 $20.1M $19M -$0.73 -- --
02/28/2023 Q4 $65.5M $69.8M -$0.30 -$0.05 -$0.25
11/08/2022 Q3 -- $76.3M -$0.65 -- --
08/09/2022 Q2 -- $17.3M -$0.84 -- --
05/09/2022 Q1 -- $46.5M -$0.22 -- --
03/03/2022 Q4 -- $17M -$0.45 -- --
11/02/2021 Q3 -- $13.1M -$0.93 -- --
08/03/2021 Q2 -- $3.8M -$0.95 -- --
05/06/2021 Q1 -- -- -$0.67 -- --
03/18/2021 Q4 -- -- -$0.73 -- --
11/12/2020 Q3 -- -- -$0.29 -- --
08/18/2020 Q2 -- -- -$2.01 -- --
03/31/2020 Q1 -- -- -$0.59 -- --
12/31/2019 Q4 -- -- -$0.48 -- --
09/30/2019 Q3 -- -- -$0.43 -- --
06/30/2019 Q2 -- $2M -$0.32 -- --

ADC Therapeutics SA Earnings Questions

  • How Much did ADC Therapeutics SA Generate in Revenue Last Quarter?

    ADC Therapeutics SA reported $23M worth of top line sales in its most recent quarter.

  • Did ADC Therapeutics SA Beat Earnings Last Quarter?

    ADC Therapeutics SA announced earnings per share of -$0.36 which represents a miss of analyst forecast a -- per share.

  • Is ADC Therapeutics SA Profitable?

    ADC Therapeutics SA reported $21M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for ADC Therapeutics SA EPS Next Year?

    ADC Therapeutics SA's earnings are forecast to decrease from -$1.62 per share to -$1.84 per share next year representing a decrease of -50.25%.

  • When is ADC Therapeutics SA's Earnings Date?

    ADC Therapeutics SA's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Can SharkNinja Stock Go?
How High Can SharkNinja Stock Go?

If you know popular consumer appliance brands Shark and Ninja,…

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
75
MP alert for Jul 16

MP Materials [MP] is up 20.3% over the past day.

Sell
38
NAIL alert for Jul 16

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is down 11.72% over the past day.

Sell
39
EHC alert for Jul 16

Encompass Health [EHC] is down 10.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock